Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

EyePoint Pharmaceuticals Inc. buy Stifel Nicolaus

EyePoint Pharmaceuticals Inc.
Start price
€12.30
16.07.26 / 50%
Target price
€34.88
16.07.27
Performance (%)
-62.44%
Price
€4.92
19.08.26
Summary
This prediction is currently active. The BUY prediction by Stifel_Nicolaus for EyePoint Pharmaceuticals Inc. is performing very badly with a performance of -62.44%. This prediction currently runs until 16.07.27. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
EyePoint Pharmaceuticals Inc. -55.888% -55.888%
iShares Core DAX® -1.059% 5.007%
iShares Nasdaq 100 -2.387% 0.864%
iShares Nikkei 225® -4.361% 1.211%
iShares S&P 500 -1.778% 1.391%

Comments by Stifel_Nicolaus for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -62.44%
Target price 34.884
Change
Ends at 16.07.27

Eyepoint Pharmaceuticals (EYPT) is now covered by Stifel Nicolaus. They set a "buy" rating and a $40.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat

Stifel Nicolaus 
0
Report Share
16.07.26